STATE STREET CORP - EFFECTOR THERAPEUTICS INC ownership

EFFECTOR THERAPEUTICS INC's ticker is and the CUSIP is 28202V108. A total of 38 filers reported holding EFFECTOR THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of EFFECTOR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$12,049
-27.7%
20,0850.0%0.00%
Q2 2023$16,675
+130.7%
20,0850.0%0.00%
Q1 2023$7,229
-57.9%
20,085
-50.0%
0.00%
Q4 2022$17,176
+56.1%
40,170
+100.0%
0.00%
Q3 2022$11,000
-62.1%
20,0850.0%0.00%
Q2 2022$29,000
-57.4%
20,085
+18.1%
0.00%
Q1 2022$68,00017,0000.00%
Other shareholders
EFFECTOR THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 6,822,114$5,594,1332.41%
OUP Management Co., LLC 1,025,697$851,5341.45%
Column Group LLC 4,309,329$3,577,6051.39%
SECTORAL ASSET MANAGEMENT INC 2,382,644$1,978,0710.33%
Carlyle Group Inc. 4,822,114$3,954,1330.14%
Sea Otter Advisors LLC 263,942$219,1250.12%
Parallel Advisors, LLC 1,693,559$1,405,9930.04%
Oasis Management Co Ltd. 100,000$83,0200.02%
CVI Holdings, LLC 15,000$12,4500.01%
Blackstone Inc. 1,308,587$1,086,3890.01%
View complete list of EFFECTOR THERAPEUTICS INC shareholders